Archive · 28 Dec 2025
Weight Loss Injections Dominate 2025
In 2025, new weight loss injections like Wegovy, Mounjaro, and Ozempic were introduced in India.
These medications help control blood sugar and reduce appetite, but experts say they are not enough on their own.
A case study showed that even these strong drugs won't work if your body is in 'survival mode' due to poor lifestyle habits.
Experts advise that to keep the weight off and stay healthy, you need to make long-term changes like eating better, exercising, managing stress, and getting enough sleep.
Medications can help, but they can't replace these healthy habits.
Three major GLP-1 medications were launched in India in 2025: Wegovy, Mounjaro, and Ozempic.
These injections help control blood sugar and reduce appetite but are not a complete solution for weight loss.
Experts emphasize that lifestyle changes, including diet, exercise, stress management, and sleep, are crucial for metabolic stability.
A case study highlighted that even GLP-1 medications may not work if the body is in 'survival mode' due to poor lifestyle habits.
Long-term lifestyle changes are necessary to maintain weight loss and improve metabolic markers like blood sugar and cholesterol.
- Who
- Experts and individuals using GLP-1 medications
- What
- Launch of weight loss injections and the importance of lifestyle changes for metabolic stability
- When
- 2025
- Where
- India
- Why
- To manage type 2 diabetes and obesity, and to highlight the importance of lifestyle changes for effective weight loss
- GLP-1 Medications Launched in 2025
- Wegovy (June 2025), Mounjaro (March 2025), Ozempic (Semaglutide)
- Expert Advice
- Lifestyle changes are crucial for metabolic stability
- Case Study
- 52-year-old woman's metabolism did not respond to Mounjaro without lifestyle changes
- Recommended Lifestyle Changes
- Moderate exercise, balanced diet, stress management, adequate sleep
- Long-term Health
- Sustainable health requires long-term lifestyle changes, not just medication